Bill Text: US HB4629 | 2019-2020 | 116th Congress | Introduced


Bill Title: Star Rating for Biosimilars Act

Spectrum: Bipartisan Bill

Status: (Introduced) 2019-10-08 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. [HB4629 Detail]

Download: US_Congress-2019-HB4629-Introduced.pdf
It appears your computer is unable to display this document, however you can download the file from the links above.
feedback